Masimo | MASI - Assets


Masimo reported $1.82B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Accuray USD 456.82M 13.42M Sep/2025
Align Technology USD 6.23B 141K Dec/2025
AngioDynamics USD 285.41M 6.14M Feb/2025
Artivion USD 857.66M 19.27M Sep/2025
AtriCure USD 654.18M 18.74M Dec/2025
Avanos Medical USD 1.07B 6M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
General Electric Aerospace USD 130.17B 1.93B Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
Masimo USD 1.82B 585.1M Sep/2025
Medtronic USD 91.35B 374M Sep/2025
Orthofix International USD 832.61M 4.55M Sep/2025
Owens Minor USD 2.45B 1.58B Dec/2025
ResMed USD 8.5B 195.02M Dec/2025
Steris USD 10.59B 180.7M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 7.87B 496.72M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025